(Q36445527)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16608418%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16608418%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16608418%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Michael E Pichichero

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16608418%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

David R Johnson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16608418%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

1 reference

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16608418%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16608418%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16608418%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16608418%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

175-187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16608418%20AND%20SRC:MED&resulttype=core&format=json

Clinical presentation of pertussis in fully immunized children in Lithuania

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

The science and fiction of the "resurgence" of pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Epidemiology of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Health burden of pertussis in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Clinical practice. Pertussis--not just for kids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Pertussis sources of infection and routes of transmission in the vaccination era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Infant pertussis: who was the source?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

National study of infants hospitalized with pertussis in the acellular vaccine era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Health burden of pertussis in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Summary: health and economic burden of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Pertussis: the trials and tribulations of old and new pertussis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

The pertussis vaccine controversy in Great Britain, 1974-1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Acellular pertussis vaccines for adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Acellular pertussis vaccine safety and efficacy in children, adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Principles of pediatric combination vaccines and practical issues related to use in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents: implications for the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Potential strategies to reduce the burden of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Adolescent and adult pertussis vaccination: computer simulations of five new strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Immunogenicity and reactogenicity of a combined adsorbed tetanus toxoid, low dose diphtheria toxoid, five component acellular pertussis and inactivated polio vaccine in six-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Economic burden of pertussis and the impact of immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Hospitalization for pertussis: profiles and case costs by age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Pertussis Immunization of Adolescents in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Pertussis: old foe, persistent problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Prevention of pertussis among adolescents by vaccination: taking action on what we know and acknowledging what we do not know

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

Pertussis in adolescents and adults: should we vaccinate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.175

21 January 2018

Identifiers

DOI

10.1586/14760584.5.2.175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16608418%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference